Isolated Use of Vibration Perception Thresholds and Semmes-Weinstein Monofilament in Diagnosing Diabetic Polyneuropathy: "The North Catalonia Diabetes Study"

Nursing Clinics of North America

Volumn 42, Issue 1, 2007, Pages 59-66

  Jurado, Jeroni ^a   Ybarra, Juan ^b   Pou, Josep Maria ^b  

^a Primary Care   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETIC FOOT; DIABETIC NEUROPATHY; EVALUATION; FEMALE; HUMAN; INSTRUMENTATION; MALE; NEUROLOGIC EXAMINATION; NURSING; PERCEPTIVE THRESHOLD; PREDICTION AND FORECASTING; REVIEW; ROC CURVE; SENSITIVITY AND SPECIFICITY; VIBRATION;

DIABETIC FOOT; DIABETIC NEUROPATHIES; DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SENSORY THRESHOLDS; VIBRATION;

EID: 33846508663     PISSN: 00296465     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnur.2006.11.006     Document Type: Review

References (32)

1. Reiber G.E., Vileikyte L., Boyko E.J., et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 22 (1999) 157-162
2. Wild S., Roglic G., Green A., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
3. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
4. Tesfaye S., Chaturvedi N., Eaton S.E.M., et al., for the EURODIAB Prospective Complications Study Group. Vascular risk factors and diabetic neuropathy. N Engl J Med 352 (2005) 341-350
5. Vinik A.I., Erbas T., Stansberry K., et al. Small fiber neuropathy and neurovascular disturbances in diabetes mellitus. Exp Clin Endocrinol Diabetes 109 Suppl 2 (2001) S451-S473
6. Smith A.G., Russell J., Feldman E.L., et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 29 (2006) 1294-1299
7. Price S.A., Dent C., Duran-Jimenez B., et al. Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy. Diabetes 55 (2006) 1847-1854
8. Vinik A.I., Bril V., Litchy W.J., et al. Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy. Muscle Nerve 32 5 (2005) 619-625
9. Boulton A.J., and Vileikyte L. The diabetic foot: the scope of the problem. J Fam Pract 49 Suppl 11 (2000) S3-S8
10. American Diabetes Association. American Academy of Neurology: Report and recommendations of the San Antonio Conference on Diabetic Neuropathy (Consensus Statement). Diabetes Care 11 (1988) 592-597
11. Jurado J., Bataller F., Dorca A., et al. Diabetic foot risk factors in diabetic patients with and without polyneuropathy (The North Catalonia Diabetes Study). Diabetologia 47 (2004) A373-A374
12. Jurado J., Ybarra J., and Pou J.M. The North Catalonia Diabetes Study (NCDS): use of vibration perception thresholds and SW monofilament for diabetic polyneuropathy diagnosis in primary care. Diabetes 54 (2005) A68
13. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
14. Young M.J., Boulton A.J.M., Macleod A.K., et al. A multicenter study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36 (1993) 150-154
15. Feldman E.L., Stevens M.J., Thomas P.K., et al. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17 11 (1994) 1281-1289
16. Liniger C., Albeanu A., Bloise D., et al. The tuning fork revisited. Diabet Med 7 (1990) 859-864
17. Olmos P.R., Cataland S., O'Dorisio T.M., et al. The Semmes-Weinstein monofilament as a potential predictor of foot ulceration in patients with noninsulin-dependent diabetes. Am J Med Sci 309 (1995) 76-82
18. Boulton A.J.M., Vinik A.I., Arezzo J.C., et al. Diabetic neuropathies. A statement by the American Diabetes Association. Diabetes Care 28 (2005) 956-962
19. Boulton A.J.M., Gries F.A., and Jervell J.A. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med 15 (1998) 508-514
20. Adler A.I., Boyko E.J., Ahroni J.H., et al. Lower-extremity amputation in diabetes. Diabetes Care 22 1 (1999) 1029-1035
21. Adler A.I., Boyko E.J., Ahroni A.H., et al. Risk factors for diabetic peripheral sensory neuropathy. Diabetes Care 20 1 (1997) 1162-1167
22. Young M.J., Breddy L., Veves A., et al. The prediction of diabetic neuropathic foot ulcerations using vibratory perception thresholds. Diabetes Care 17 (1994) 557-560
23. Kumar S., Fernando D.J.S., Veves A., et al. Semmes Weinstein monofilaments: a simple, effective and inexpensive device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract 13 (1991) 63-68
24. Meijer J.W.G., Smit A.J., Lefrandt J.D., et al. Back to basics in diagnosing diabetic polyneuropathy with the tuning fork!. Diabetes Care 28 (2005) 2201-2205
25. Kamei N., Yamane K., Nakanishi S., et al. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening. J Diabetes Complications 19 (2005) 47-53
26. Kästenbauer T., Sauseng S., Barth H., et al. The value of the Rydel-Seifer tuning fork as a predictor of diabetic polyneuropathy compared with a neurothesiometer. Diabet Med 21 (2004) 563-567
27. Mayfield J.A., Sugarman J.R., and Peterson K.A. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J Fam Pract 49 (2000) S17-S29
28. Bell-Krotoski J.A., and Buford Jr. W.L. The force/time relationship of clinically used sensory testing instruments. J Hand Ther 10 (1997) 297-309
29. Booth J., and Young M.J. Differences in the performance of commercially available 10-g monofilaments. Diabetes Care 23 (2000) 984-988
30. McGill M., Molyneaux L.M., and Yue D.K. Use of the Semmes Weinstein 5.07/10grm monofilament: the long and the short of it. Diabet Med 15 (1998) 615-617
31. Vinik A.I., Holland M.T., LeBeau J.M., et al. Diabetic neuropathies. Diabetes Care 15 (1992) 1926-1975
32. Edmonds M.E., Van Acker K., and Foster A.V. Education and the diabetic foot. Diabet Med 13 Suppl 1 (1996) S61-S64